GlassScriptPhysician profile
Bonnie Otto
NPI 1053428177
$2,801.01
in general payments reported to CMS, 2019-2025
34 companies · $713 in 2025
The $713 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $295 · 2022: $431 · 2023: $637 · 2024: $726 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,076.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,075.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $427.10 | 2024-2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $266.81 | 2021-2025 | |
| Boston Scientific Corporation | $245.19 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System, Rotapro |
| Edwards Lifesciences Corporation | $183.00 | 2022-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.51 | 2021-2025 | Jardiance |
| W. L. Gore & Associates, INC. | $158.59 | 2022-2023 | C3 Delivery System, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $127.35 | 2021-2025 | Lifevest |
| Shockwave Medical, INC | $117.03 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $108.15 | 2021-2023 | Xarelto |
| Angiodynamics, INC. | $92.00 | 2022-2024 | Auryon Laser System 100-120 Vac |
| Pfizer INC. | $89.44 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $82.42 | 2023-2024 | Verquvo, Belsomra, Steglatro |
| Novo Nordisk INC | $67.96 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Abbott Laboratories | $64.83 | 2021-2023 | Jeti |
| Amgen INC. | $64.60 | 2023-2025 | Repatha, Otezla, Repatha |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $62.14 | 2023-2024 | Mounjaro, Trulicity, Zepbound |
| Astrazeneca Pharmaceuticals LP | $47.70 | 2021-2025 | Wainua |
| Medtronic, INC. | $47.38 | 2021-2023 | In.Pact Admiral |
| Exact Sciences Corporation | $46.01 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Scpharmaceuticals INC. | $42.88 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $41.40 | 2024-2025 | Camzyos |
| Ironwood Pharmaceuticals, INC | $28.47 | 2023-2024 | Linzess |
| Lundbeck LLC | $21.57 | 2025 | Rexulti |
| Cvrx, INC. | $20.72 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $20.16 | 2023 | Inpefa |
| Otsuka America Pharmaceutical, INC. | $18.94 | 2025 | Rexulti |
| Valinor Pharma, LLC | $18.44 | 2024 | Movantik |
| Surmodics, INC. | $17.48 | 2023 | Sublime Radial Access Guide Sheath, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Sanofi-Aventis U.S. LLC | $16.61 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.08 | 2024 | |
| Esperion Therapeutics, INC. | $15.93 | 2025 | Nexletol |
| Xeris Pharmaceuticals, INC. | $15.81 | 2025 | Gvoke Hypopen |
| Cordis US Corp. | $15.25 | 2024 | Brite Tip Radianz |
| Bard Peripheral Vascular, INC. | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bonnie Otto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.